Hemodialysis

Liver Enzyme Test Inadequate For Screening Patients For HCV

Published in Hepatitis Weekly, March 26th, 2001

by Sonia Nichols, staff medical writer - Researchers report elevated alanine aminotransferase (ALT) is of no use for screening hemodialysis patients for hepatitis C virus (HCV) infections.

Patients on hemodialysis (HD) face an increased risk for acquiring HCV. Doctors advise that HD patients be screened for HCV with tests that measure ALT, say investigators at the University of California at Los Angeles. However, these researchers advise ALT levels, used to detect inadequate liver function, are of no value for screening HD patients for viral hepatitis.

"We screened 2,440 HD patients from 39 dialysis centers for viral infection by using hepatitis...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-03-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry